{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:24:38Z","timestamp":1764588278828,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Grants to Promote Collaborative and Translational Research (GCAT), Loma Linda University","award":["699515"],"award-info":[{"award-number":["699515"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["World Jnl Ped Surgery"],"accepted":{"date-parts":[[2021,11,29]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Necrotizing enterocolitis (NEC) is the leading gastrointestinal cause of death in premature infants and causes long-term disabilities. Previously, enteral heparin-binding epidermal growth factor-like growth factor (HB-EGF) administered after birth demonstrated decreased incidence and severity of NEC in a neonatal animal model of NEC. We investigated the potential prophylactic strategy of preventing NEC using prenatally administered HB-EGF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An HB-EGF (800 \u00b5g\/kg\/dose) dose was injected into pregnant rats via tail vein or intraperitoneal route 2 hours prior to delivery. After cesarean section (C-section) at 21 days\u2019 gestation, the rat pups were subjected to the NEC protocol by inducing stressors: hypoxia, hypothermia, hypertonic feeds, and orogastric gavage of lipopolysaccharide (2 mg\/kg). Postnatally, pups were monitored for 96 hours and assessed for the development of clinical and postmortem histological NEC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The experimental NEC incidence in untreated, stressed rat pups was 66%. Compared with untreated pups, the maternal administration of HB-EGF correlated with a significant NEC incidence and severity decrease in rat pups. The strongest decrease was seen when HB-EGF was administered via the intraperitoneal route 2 hours prior to C-section (66% vs 31%, *p&lt;0.05). Prenatal HB-EGF administration significantly increased pups\u2019 survival after NEC protocol exposure, with the greatest benefit observed in the group that received HB-EGF intraperitoneally 2 hours before delivery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prenatal administration of HB-EGF decreases the incidence and severity of NEC, preserves gut barrier function and increases survival. This may represent a novel prophylactic clinical strategy for NEC offered to mothers at risk of delivering a premature infant.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/wjps-2021-000345","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T11:40:36Z","timestamp":1641469236000},"page":"e000345","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Prenatal administration of heparin-binding epidermal growth factor-like growth factor in an experimental model of necrotizing enterocolitis decreased both incidence and severity of the disease"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-8398","authenticated-orcid":false,"given":"Marla Ashley","family":"Sacks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yomara Stephanie","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Propst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig W","family":"Zuppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Radulescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"2025081809564284000_5.1.e000345.1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00078.2018"},{"key":"2025081809564284000_5.1.e000345.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(03)00123-4"},{"key":"2025081809564284000_5.1.e000345.3","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181994fa0"},{"key":"2025081809564284000_5.1.e000345.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2005.05.005"},{"key":"2025081809564284000_5.1.e000345.5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1091\/mbc.1.11.811","article-title":"Isolation and characterization of a macrophage-derived heparin-binding growth factor","volume":"1","author":"Besner","year":"1990","journal-title":"Cell Regul"},{"key":"2025081809564284000_5.1.e000345.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1840698"},{"key":"2025081809564284000_5.1.e000345.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2010.05.002"},{"key":"2025081809564284000_5.1.e000345.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(01)00065-2"},{"key":"2025081809564284000_5.1.e000345.9","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.13.3342"},{"key":"2025081809564284000_5.1.e000345.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2005.10.018"},{"key":"2025081809564284000_5.1.e000345.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2009.06.035"},{"key":"2025081809564284000_5.1.e000345.12","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2002.29415"},{"key":"2025081809564284000_5.1.e000345.13","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(74)90093-1"},{"key":"2025081809564284000_5.1.e000345.14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jpedsurg.2013.03.030","article-title":"Heparin-Binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury","volume":"48","author":"Matthews","year":"2013","journal-title":"J Pediatr Surg"},{"key":"2025081809564284000_5.1.e000345.15","doi-asserted-by":"crossref","DOI":"10.1136\/wjps-2020-000109","article-title":"Animal models of necrotizing enterocolitis","volume":"3","author":"Mendez","year":"2020","journal-title":"World Jnl Ped Surgery"},{"key":"2025081809564284000_5.1.e000345.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000411","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"2025081809564284000_5.1.e000345.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70450-6"},{"key":"2025081809564284000_5.1.e000345.18","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2008.01.007"},{"key":"2025081809564284000_5.1.e000345.19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clp.2018.10.005","article-title":"Influence of growth factors on the development of necrotizing enterocolitis","volume":"46","author":"Shelby","year":"2019","journal-title":"Clin Perinatol"},{"key":"2025081809564284000_5.1.e000345.20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004454.pub3"},{"key":"2025081809564284000_5.1.e000345.21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0811"},{"key":"2025081809564284000_5.1.e000345.22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1426"},{"key":"2025081809564284000_5.1.e000345.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000239774.02904.65"},{"key":"2025081809564284000_5.1.e000345.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2009.02.020"},{"key":"2025081809564284000_5.1.e000345.25","doi-asserted-by":"publisher","DOI":"10.1089\/15230860152665073"},{"key":"2025081809564284000_5.1.e000345.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.11.013"},{"key":"2025081809564284000_5.1.e000345.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2013.11.015"},{"key":"2025081809564284000_5.1.e000345.28","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.153"}],"container-title":["World Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/wjps-2021-000345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:56:50Z","timestamp":1755536210000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjps.bmj.com\/lookup\/doi\/10.1136\/wjps-2021-000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,6]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/wjps-2021-000345"],"URL":"https:\/\/doi.org\/10.1136\/wjps-2021-000345","relation":{},"ISSN":["2516-5410"],"issn-type":[{"type":"electronic","value":"2516-5410"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}